Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
85.94
Dollar change
-0.51
Percentage change
-0.59
%
IndexS&P 500 P/E37.34 EPS (ttm)2.30 Insider Own1.58% Shs Outstand601.10M Perf Week-4.81%
Market Cap51.68B Forward P/E27.75 EPS next Y3.10 Insider Trans-4.22% Shs Float591.80M Perf Month-7.63%
Income1.40B PEG4.00 EPS next Q0.64 Inst Own82.59% Short Float1.75% Perf Quarter15.65%
Sales6.00B P/S8.61 EPS this Y9.72% Inst Trans-0.08% Short Ratio2.58 Perf Half Y23.28%
Book/sh11.06 P/B7.77 EPS next Y12.44% ROA15.89% Short Interest10.38M Perf Year-0.65%
Cash/sh2.74 P/C31.36 EPS next 5Y9.34% ROE22.52% 52W Range60.57 - 96.12 Perf YTD12.71%
Dividend Est.- P/FCF80.39 EPS past 5Y15.35% ROI19.16% 52W High-10.59% Beta1.09
Dividend TTM- Quick Ratio2.40 Sales past 5Y10.28% Gross Margin76.04% 52W Low41.89% ATR (14)2.16
Dividend Ex-Date- Current Ratio3.38 EPS Y/Y TTM-6.00% Oper. Margin27.81% RSI (14)34.51 Volatility2.74% 2.13%
Employees19800 Debt/Eq0.10 Sales Y/Y TTM11.56% Profit Margin23.35% Recom2.16 Target Price95.44
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q-5.72% Payout0.00% Rel Volume0.97 Prev Close86.45
Sales Surprise2.49% EPS Surprise0.42% Sales Q/Q13.78% EarningsApr 25 AMC Avg Volume4.02M Price85.94
SMA20-6.73% SMA50-4.45% SMA2009.09% Trades Volume3,882,058 Change-0.59%
Date Action Analyst Rating Change Price Target Change
Mar-07-24Upgrade BofA Securities Neutral → Buy
Feb-02-24Upgrade Wells Fargo Equal Weight → Overweight $94
Jan-04-24Downgrade Evercore ISI Outperform → In-line $80 → $77
Dec-11-23Downgrade Citigroup Buy → Neutral
Nov-28-23Downgrade Wolfe Research Peer Perform → Underperform $57
Sep-26-23Upgrade Oppenheimer Perform → Outperform $90
Jul-19-23Initiated Robert W. Baird Outperform $107
May-30-23Resumed Morgan Stanley Overweight $102
Mar-29-23Initiated UBS Neutral $84
Mar-08-23Downgrade Wells Fargo Overweight → Equal Weight $97 → $78
Today 01:08AM
Apr-18-24 10:01AM
07:10AM
Apr-17-24 11:01AM
Apr-12-24 04:37AM
04:30PM Loading…
Apr-07-24 04:30PM
Mar-26-24 08:02AM
Mar-25-24 09:40AM
Mar-19-24 02:24PM
01:38PM
Mar-15-24 04:02PM
10:50AM
Mar-13-24 11:57AM
Mar-11-24 02:00PM
Mar-07-24 04:57PM
11:31AM Loading…
11:31AM
Mar-06-24 09:43AM
Feb-26-24 11:54AM
Feb-23-24 07:05AM
Feb-18-24 01:26PM
Feb-15-24 09:36AM
Feb-13-24 12:09AM
Feb-09-24 02:21AM
Feb-07-24 04:11PM
11:19AM
10:31AM
09:06AM
05:54AM
Feb-06-24 07:55PM
06:00PM
05:25PM Loading…
05:25PM
04:54PM
04:44PM
04:40PM
04:15PM
07:18AM
Feb-02-24 07:00AM
06:27AM
Feb-01-24 09:15AM
07:44AM
Jan-30-24 07:05AM
06:15AM
Jan-23-24 07:07AM
Jan-19-24 11:26AM
Jan-16-24 01:20AM
Jan-03-24 07:40AM
Jan-02-24 09:00AM
Dec-20-23 05:24AM
Dec-14-23 07:49PM
Dec-11-23 12:27PM
Dec-08-23 05:11AM
Dec-07-23 05:00PM
08:30AM
Nov-26-23 05:56AM
Nov-25-23 06:58AM
Nov-24-23 11:31AM
Nov-23-23 06:06AM
Oct-30-23 11:40AM
Oct-27-23 07:30AM
Oct-26-23 06:15PM
03:06PM
02:00PM
11:33AM
11:17AM
11:12AM
10:08AM
07:23AM
07:20AM
Oct-25-23 06:00PM
06:00PM
05:40PM
04:32PM
04:15PM
04:15PM
10:08AM
06:22AM
Oct-24-23 02:00PM
Oct-23-23 03:58AM
02:18AM
Oct-20-23 11:47AM
Oct-19-23 10:01AM
08:30AM
06:54AM
Oct-18-23 12:10PM
07:05AM
Oct-17-23 04:15PM
02:01PM
08:07AM
Oct-12-23 11:40AM
Oct-10-23 12:06PM
11:33AM
Oct-05-23 12:03PM
Sep-26-23 12:04PM
11:37AM
10:09AM
Sep-21-23 07:49PM
11:40AM
Sep-20-23 12:08PM
11:36AM
Sep-15-23 11:09AM
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lippis Daniel J.CVP, JAPACApr 09 '24Option Exercise36.7585731,49518,345Apr 09 05:33 PM
Lippis Daniel J.CVP, JAPACApr 09 '24Sale92.3485779,13517,488Apr 09 05:33 PM
Lemercier Jean-Luc MCVP, EMEACLAApr 08 '24Option Exercise36.7514,400529,200188,249Apr 08 05:10 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentApr 08 '24Option Exercise36.7512,500459,37552,268Apr 08 05:10 PM
Lemercier Jean-Luc MCVP, EMEACLAApr 08 '24Sale92.3214,4001,329,472173,849Apr 08 05:10 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentApr 08 '24Sale92.3312,5001,154,14239,768Apr 08 05:10 PM
MUSSALLEM MICHAEL ADirectorApr 04 '24Option Exercise36.7529,3501,078,61233,836Apr 04 06:26 PM
MUSSALLEM MICHAEL ADirectorApr 04 '24Sale92.4229,3502,712,4184,486Apr 04 06:26 PM
Ullem Scott B.CVP, Chief Financial OfficerApr 01 '24Option Exercise36.757,255266,62126,329Apr 01 06:55 PM
Ullem Scott B.CVP, Chief Financial OfficerApr 01 '24Sale94.897,255688,42319,074Apr 01 06:55 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMar 13 '24Option Exercise36.7514,500532,87554,003Mar 13 05:44 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMar 13 '24Sale91.0114,5001,319,69639,503Mar 13 05:44 PM
Lemercier Jean-Luc MCVP, EMEACLA and JAPACMar 11 '24Option Exercise36.7514,400529,200187,984Mar 11 06:00 PM
Lemercier Jean-Luc MCVP, EMEACLA and JAPACMar 11 '24Sale91.6814,4001,320,149173,584Mar 11 06:00 PM
Lippis Daniel J.CVP, JAPACMar 07 '24Option Exercise36.751,71563,02618,928Mar 07 06:22 PM
Lippis Daniel J.CVP, JAPACMar 07 '24Sale90.981,715156,03117,213Mar 07 06:22 PM
MUSSALLEM MICHAEL ADirectorMar 04 '24Option Exercise36.7529,3501,078,61233,836Mar 04 07:16 PM
MUSSALLEM MICHAEL ADirectorMar 04 '24Sale86.6729,3502,543,7374,486Mar 04 07:16 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 29 '24Option Exercise36.757,255266,62126,329Feb 29 05:12 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 29 '24Sale85.597,255620,92319,074Feb 29 05:12 PM
GALLAHUE KIERANDirectorFeb 23 '24Option Exercise36.867,056260,10710,757Feb 26 05:52 PM
GALLAHUE KIERANDirectorFeb 23 '24Sale87.613,058267,91167,219Feb 26 05:52 PM
Chopra DaveenCVP, TMTTFeb 21 '24Option Exercise59.267,000414,79730,950Feb 21 05:52 PM
Chopra DaveenCVP, TMTTFeb 21 '24Sale86.748,200711,27222,750Feb 21 05:52 PM
Szyman Catherine M.CVP, Critical CareFeb 15 '24Option Exercise36.7527,000992,25061,814Feb 15 05:25 PM
Szyman Catherine M.CVP, Critical CareFeb 15 '24Sale85.6227,0002,311,65434,814Feb 15 05:25 PM
Szyman Catherine M.CVP, Critical CareFeb 13 '24Option Exercise36.7520,000735,00054,814Feb 15 05:25 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentFeb 13 '24Option Exercise36.7511,000404,25050,503Feb 13 04:51 PM
Szyman Catherine M.CVP, Critical CareFeb 13 '24Sale86.4620,0001,729,20034,814Feb 15 05:25 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentFeb 13 '24Sale85.8311,000944,15539,503Feb 13 04:51 PM
SELLERS ROBERT W.A.SVP, Corporate ControllerFeb 12 '24Option Exercise36.7512,210448,71825,297Feb 12 05:44 PM
SELLERS ROBERT W.A.SVP, Corporate ControllerFeb 12 '24Sale87.0012,2101,062,27013,087Feb 12 05:44 PM
STONE HEISZ LESLIEDirectorFeb 08 '24Option Exercise36.867,056260,10734,036Feb 08 06:08 PM
STONE HEISZ LESLIEDirectorFeb 08 '24Sale86.457,056609,99126,980Feb 08 06:08 PM
MUSSALLEM MICHAEL ADirectorFeb 05 '24Option Exercise36.7529,3501,078,61233,836Feb 05 06:37 PM
MUSSALLEM MICHAEL ADirectorFeb 05 '24Sale87.4929,3502,567,7544,486Feb 05 06:37 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 01 '24Option Exercise36.757,255266,62126,503Feb 01 05:52 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 01 '24Sale78.297,255567,99419,248Feb 01 05:52 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJan 12 '24Option Exercise36.7510,000367,50049,503Jan 12 05:36 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJan 12 '24Sale75.6710,000756,70039,503Jan 12 05:36 PM
MUSSALLEM MICHAEL ADirectorJan 05 '24Option Exercise36.7529,3501,078,61233,836Jan 05 07:19 PM
MUSSALLEM MICHAEL ADirectorJan 05 '24Sale72.9829,3502,142,0894,486Jan 05 07:19 PM
Ullem Scott B.CVP, Chief Financial OfficerDec 29 '23Option Exercise36.7514,510533,24233,758Dec 29 04:25 PM
Ullem Scott B.CVP, Chief Financial OfficerDec 29 '23Sale76.5514,5101,110,79419,248Dec 29 04:25 PM
Chopra DaveenCVP, TMTTDec 15 '23Option Exercise59.267,000414,79730,950Dec 15 05:22 PM
Chopra DaveenCVP, TMTTDec 15 '23Sale78.257,000547,72423,950Dec 15 05:22 PM
MUSSALLEM MICHAEL ADirectorDec 13 '23Option Exercise36.7529,3501,078,61233,836Dec 13 07:04 PM
Wood Larry LGlobal President TAVR & SurgDec 13 '23Option Exercise45.288,658392,006222,452Dec 13 07:04 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentDec 13 '23Option Exercise36.758,000294,00047,503Dec 13 07:04 PM
MUSSALLEM MICHAEL ADirectorDec 13 '23Sale74.6229,3502,190,0434,486Dec 13 07:04 PM
Wood Larry LGlobal President TAVR & SurgDec 13 '23Sale71.868,658622,164213,794Dec 13 07:04 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentDec 13 '23Sale71.868,000574,88039,503Dec 13 07:04 PM
Chopra DaveenCVP, TMTTDec 06 '23Option Exercise59.263,500207,39827,450Dec 06 05:01 PM
Chopra DaveenCVP, TMTTDec 06 '23Sale70.003,500245,00623,950Dec 06 05:01 PM
Wood Larry LGlobal President TAVR & SurgNov 13 '23Option Exercise45.288,660392,096222,454Nov 13 05:21 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentNov 13 '23Option Exercise36.756,000220,50045,503Nov 13 05:21 PM
Wood Larry LGlobal President TAVR & SurgNov 13 '23Sale65.308,660565,460213,794Nov 13 05:21 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentNov 13 '23Sale65.306,000391,78039,503Nov 13 05:21 PM
MUSSALLEM MICHAEL ADirectorNov 03 '23Option Exercise36.7529,3501,078,61233,836Nov 06 06:33 PM
MUSSALLEM MICHAEL ADirectorNov 03 '23Sale67.1829,3501,971,7334,486Nov 06 06:33 PM
Ullem Scott B.CVP, Chief Financial OfficerOct 31 '23Option Exercise36.757,255266,62126,503Oct 31 05:22 PM
Ullem Scott B.CVP, Chief Financial OfficerOct 31 '23Sale62.667,255454,56919,248Oct 31 05:22 PM
Wood Larry LGlobal President TAVR & SurgOct 13 '23Option Exercise45.288,660392,096222,454Oct 13 05:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentOct 13 '23Option Exercise36.755,000183,75044,503Oct 13 05:01 PM
Wood Larry LGlobal President TAVR & SurgOct 13 '23Sale70.008,660606,198213,794Oct 13 05:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentOct 13 '23Sale69.985,000349,90939,503Oct 13 05:01 PM
Szyman Catherine M.CVP, Critical CareOct 10 '23Option Exercise36.755,000183,75039,814Oct 10 06:23 PM
Szyman Catherine M.CVP, Critical CareOct 10 '23Sale72.685,000363,40034,814Oct 10 06:23 PM
Chopra DaveenCVP, TMTTOct 03 '23Option Exercise59.268,500503,68232,450Oct 03 04:58 PM
Chopra DaveenCVP, TMTTOct 03 '23Sale70.008,500595,00023,950Oct 03 04:58 PM
MUSSALLEM MICHAEL ADirectorOct 02 '23Option Exercise36.7529,3501,078,61233,836Oct 02 06:51 PM
MUSSALLEM MICHAEL ADirectorOct 02 '23Sale68.8429,3502,020,4544,486Oct 02 06:51 PM
Ullem Scott B.CVP, Chief Financial OfficerSep 29 '23Option Exercise36.757,255266,62126,503Sep 29 04:49 PM
Ullem Scott B.CVP, Chief Financial OfficerSep 29 '23Sale69.547,255504,52719,248Sep 29 04:49 PM
Wood Larry LGlobal President TAVR & SurgSep 14 '23Option Exercise45.288,660392,096222,454Sep 14 08:00 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSep 14 '23Option Exercise36.754,500165,37544,003Sep 14 08:00 PM
Wood Larry LGlobal President TAVR & SurgSep 14 '23Sale73.638,660637,615213,794Sep 14 08:00 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSep 14 '23Sale73.714,500331,69539,503Sep 14 08:00 PM
Szyman Catherine M.CVP, Critical CareSep 08 '23Option Exercise36.755,000183,75039,814Sep 08 05:29 PM
Szyman Catherine M.CVP, Critical CareSep 08 '23Sale76.005,000380,00034,814Sep 08 05:29 PM
Chopra DaveenCVP, TMTTSep 06 '23Option Exercise59.268,500503,68232,450Sep 06 05:09 PM
Chopra DaveenCVP, TMTTSep 06 '23Sale76.078,500646,60923,950Sep 06 05:09 PM
MUSSALLEM MICHAEL ADirectorSep 05 '23Option Exercise36.7529,3501,078,61233,836Sep 05 07:08 PM
MUSSALLEM MICHAEL ADirectorSep 05 '23Sale75.8629,3502,226,4914,486Sep 05 07:08 PM
Ullem Scott B.CVP, Chief Financial OfficerAug 31 '23Option Exercise36.757,255266,62126,503Aug 31 05:34 PM
Ullem Scott B.CVP, Chief Financial OfficerAug 31 '23Sale77.797,255564,36619,248Aug 31 05:34 PM
Chopra DaveenCVP, TMTTAug 29 '23Sale76.691,500115,04023,950Aug 29 05:31 PM
Wood Larry LGlobal President TAVR & SurgAug 14 '23Option Exercise45.286,421290,722220,215Aug 14 06:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentAug 14 '23Option Exercise36.754,500165,37544,003Aug 14 06:02 PM
Wood Larry LGlobal President TAVR & SurgAug 14 '23Sale79.306,421509,185213,794Aug 14 06:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentAug 14 '23Sale79.304,500356,85039,503Aug 14 06:02 PM
STONE HEISZ LESLIEDirectorAug 10 '23Sale78.873,303260,50926,980Aug 10 05:48 PM
Szyman Catherine M.CVP, Critical CareAug 09 '23Option Exercise36.755,000183,75039,814Aug 09 05:44 PM
Szyman Catherine M.CVP, Critical CareAug 09 '23Sale78.645,000393,18534,814Aug 09 05:44 PM
MUSSALLEM MICHAEL ADirectorAug 07 '23Option Exercise36.7529,3501,078,61283,602Aug 07 07:20 PM
MUSSALLEM MICHAEL ADirectorAug 07 '23Sale79.8729,3502,344,09554,252Aug 07 07:20 PM
Ullem Scott B.CVP, Chief Financial OfficerJul 31 '23Option Exercise36.757,255266,62126,503Jul 31 05:23 PM
Ullem Scott B.CVP, Chief Financial OfficerJul 31 '23Sale84.357,255611,95919,248Jul 31 05:23 PM
Wood Larry LGlobal President TAVR & SurgJul 14 '23Option Exercise45.288,660392,096222,454Jul 14 05:58 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJul 14 '23Option Exercise36.753,500128,62543,003Jul 14 05:58 PM